Drug Profile
GnRH glycs PPD vaccine - Protherics
Alternative Names: GnRH glycs PPDLatest Information Update: 16 Jul 2002
Price :
$50
*
At a glance
- Originator Protherics
- Class Hormones; Vaccines
- Mechanism of Action Gonadotropin releasing hormone inhibitors; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Breast cancer
Most Recent Events
- 16 Jul 2002 Discontinued - Preclinical for Breast cancer in United Kingdom (Intraperitoneal)
- 21 Oct 1999 Proteus International has merged with Therapeutic Antibodies to form Protherics
- 16 Oct 1997 New profile